Federal Register - September 24, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
53036
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices except for permission to market or use the product commercially, the 184
patent would be eligible for an extension of the patent term under 35
U.S.C. 156. Because it appears the approval phase of the regulatory review period will continue beyond the extended expiration date of the patent, i.e., October 6, 2021, interim extension of the 184 patents term under 35 U.S.C.
156d5 is appropriate.
An interim extension under 35 U.S.C.
156d5 of the term of U.S. Patent No.
7,259,184 is granted for a period of one year from the extended expiration date of the 184 patent.
www.fisheries.noaa.gov/national/
partners/marine-fisheries-advisorycommittee-meeting-materials-andsummaries by October 4, 2021.
Dated: September 21, 2021.
Jennifer L. Lukens, Federal Program Officer, Marine Fisheries Advisory Committee, National Marine Fisheries Service.
FR Doc. 202120782 Filed 92321; 8:45 am BILLING CODE 351022P
DEPARTMENT OF COMMERCE
Patent and Trademark Office Docket No. PTOP20210049
Grant of Interim Extension of the Term of U.S. Patent No. 7,259,184;
Vernakalant Hydrochloride United States Patent and Trademark Office, Department of Commerce.
ACTION: Notice of interim patent term extension.
Robert Bahr, Deputy Commissioner for Patents, United States Patent and Trademark Office.
FR Doc. 202120764 Filed 92321; 8:45 am BILLING CODE 351016P
AGENCY:
DEPARTMENT OF COMMERCE
Patent and Trademark Office
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,259,184
184 patent.
FOR FURTHER INFORMATION CONTACT: Ali Salimi, Senior Legal Advisor, Office of Patent Legal Administration, by telephone at 5712720909 or by email to ali.salimi@uspto.gov.
SUPPLEMENTARY INFORMATION: 35 U.S.C.
156 generally provides that the term of a patent may be extended for a period of up to five years, if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review. 35
U.S.C. 156d5 generally provides that the term of such a patent may be extended for no more than five interim periods of up to one year each, if the approval phase of the regulatory review period is reasonably expected to extend beyond the expiration date of the patent.
On July 14, 2020, Correvio International Sarl, the owner of record of the 184 patent, timely filed an application under 35 U.S.C. 156d5
for an interim extension of the term of the 184 patent. The 184 patent claims a method of using the product vernakalant hydrochloride. The application for interim patent term extension indicates that New Drug Application No. 22034 for vernakalant hydrochloride was submitted to the Food and Drug Administration FDA on December 19, 2006, and that the FDAs review thereof is ongoing.
Review of the interim patent term extension application indicates that, SUMMARY:
VerDate Sep<11>2014
16:50 Sep 23, 2021
Jkt 253001
Docket No. PTOP20210050
Grant of Interim Extension of the Term of U.S. Patent No. 7,524,879;
Vernakalant Hydrochloride
a method of using the product vernakalant hydrochloride. The application for interim patent term extension indicates that New Drug Application No. 22034 for vernakalant hydrochloride was submitted to the Food and Drug Administration FDA on December 19, 2006, and that the FDAs review thereof is ongoing.
Review of the interim patent term extension application indicates that, except for permission to market or use the product commercially, the 879
patent would be eligible for an extension of the patent term under 35
U.S.C. 156. Because it appears the approval phase of the regulatory review period will continue beyond the extended expiration date of the patent, i.e., October 6, 2021, interim extension of the 879 patents term under 35 U.S.C.
156d5 is appropriate.
An interim extension under 35 U.S.C.
156d5 of the term of U.S. Patent No.
7,5242,879 is granted for a period of one year from the extended expiration date of the 879 patent.
Robert Bahr, Deputy Commissioner for Patents, United States Patent and Trademark Office.
FR Doc. 202120765 Filed 92321; 8:45 am
United States Patent and Trademark Office, Department of Commerce.
ACTION: Notice of interim patent term extension.
BILLING CODE 351016P
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,524,879
879 patent.
FOR FURTHER INFORMATION CONTACT: Ali Salimi, Senior Legal Advisor, Office of Patent Legal Administration, by telephone at 5712720909 or by email to ali.salimi@uspto.gov.
SUPPLEMENTARY INFORMATION: 35 U.S.C.
156 generally provides that the term of a patent may be extended for a period of up to five years, if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review. 35
U.S.C. 156d5 generally provides that the term of such a patent may be extended for no more than five interim periods of up to one year each, if the approval phase of the regulatory review period is reasonably expected to extend beyond the expiration date of the patent.
On July 14, 2020, Correvio International Sarl, the owner of record of the 879 patent, timely filed an application under 35 U.S.C. 156d5
for an interim extension of the term of the 879 patent. The 879 patent claims
Docket No. PTOP20210048
AGENCY:
SUMMARY:
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Grant of Interim Extension of the Term of U.S. Patent No. 7,057,053;
Vernakalant Hydrochloride United States Patent and Trademark Office, Department of Commerce.
ACTION: Notice of interim patent term extension.
AGENCY:
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,057,053
053 patent.
FOR FURTHER INFORMATION CONTACT: Ali Salimi, Senior Legal Advisor, Office of Patent Legal Administration, by telephone at 5712720909 or by email to ali.salimi@uspto.gov.
SUPPLEMENTARY INFORMATION: 35 U.S.C.
156 generally provides that the term of a patent may be extended for a period of up to five years, if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review. 35
U.S.C. 156d5 generally provides that the term of such a patent may be SUMMARY:
E:FRFM24SEN1.SGM
24SEN1
